ID: ALA3786883
Chembl Id: CHEMBL3786883
PubChem CID: 127034200
Max Phase: Preclinical
Molecular Formula: C15H12FNO
Molecular Weight: 241.26
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc(C)n2c1C=C(c1ccccc1F)C2=O
Standard InChI: InChI=1S/C15H12FNO/c1-9-7-10(2)17-14(9)8-12(15(17)18)11-5-3-4-6-13(11)16/h3-8H,1-2H3
Standard InChI Key: AMOBYOBUNXRZMN-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 241.26 | Molecular Weight (Monoisotopic): 241.0903 | AlogP: 3.44 | #Rotatable Bonds: 1 |
| Polar Surface Area: 22.00 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
| #RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.20 | CX LogD: 3.20 |
| Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.75 | Np Likeness Score: -0.94 |
| 1. Kirk NS, Bezos A, Willis AC, Sudta P, Suksamrarn S, Parish CR, Ranson M, Kelso MJ.. (2016) Synthesis and preliminary evaluation of 5,7-dimethyl-2-aryl-3H-pyrrolizin-3-ones as angiogenesis inhibitors., 26 (7): [PMID:26912111] [10.1016/j.bmcl.2016.02.033] |
Source(1):
